Literature DB >> 27023167

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation.

Cynthia A Gossman1, David M Linn2, Cindy Linn3.   

Abstract

Glaucoma is a disease of the central nervous system affecting retinal ganglion cells (RGCs). RGC axons making up the optic nerve carry visual input to the brain for visual perception. Damage to RGCs and their axons leads to vision loss and/or blindness. Although the specific cause of glaucoma is unknown, the primary risk factor for the disease is an elevated intraocular pressure. Glaucoma-inducing procedures in animal models are a valuable tool to researchers studying the mechanism of RGC death. Such information can lead to the development of effective neuroprotective treatments that could aid in the prevention of vision loss. The protocol in this paper describes a method of inducing glaucoma - like conditions in an in vivo rat model where 50 µl of 2 M hypertonic saline is injected into the episcleral venous plexus. Blanching of the vessels indicates successful injection. This procedure causes loss of RGCs to simulate glaucoma. One month following injection, animals are sacrificed and eyes are removed. Next, the cornea, lens, and vitreous are removed to make an eyecup. The retina is then peeled from the back of the eye and pinned onto sylgard dishes using cactus needles. At this point, neurons in the retina can be stained for analysis. Results from this lab show that approximately 25% of RGCs are lost within one month of the procedure when compared to internal controls. This procedure allows for quantitative analysis of retinal ganglion cell death in an in vivo rat glaucoma model.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27023167      PMCID: PMC4828975          DOI: 10.3791/53831

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  58 in total

Review 1.  Leading causes of blindness worldwide.

Authors:  J M J Roodhooft
Journal:  Bull Soc Belge Ophtalmol       Date:  2002

2.  Association between risk factors and glaucomatous damage in untreated primary open-angle glaucoma.

Authors:  Konstantin Gugleta; Anna Polunina; Asan Kochkorov; Nicolas Waldmann; Natalie Portmann; Robert Katamay; Josef Flammer; Selim Orgul
Journal:  J Glaucoma       Date:  2013-08       Impact factor: 2.503

3.  Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure.

Authors:  M Sherwood; J Brandt
Journal:  Surv Ophthalmol       Date:  2001-05       Impact factor: 6.048

4.  The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice.

Authors:  Rebecca M Sappington; Brian J Carlson; Samuel D Crish; David J Calkins
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

5.  Long-term survival of retinal ganglion cells following optic nerve section in adult bcl-2 transgenic mice.

Authors:  M C Cenni; L Bonfanti; J C Martinou; G M Ratto; E Strettoi; L Maffei
Journal:  Eur J Neurosci       Date:  1996-08       Impact factor: 3.386

6.  Trabeculectomy. Preliminary report of a new method.

Authors:  J E Cairns
Journal:  Am J Ophthalmol       Date:  1968-10       Impact factor: 5.258

7.  Dorzolamide, visual function and ocular hemodynamics in normal-tension glaucoma.

Authors:  A Harris; O Arend; L Kagemann; M Garrett; H S Chung; B Martin
Journal:  J Ocul Pharmacol Ther       Date:  1999-06       Impact factor: 2.671

8.  Effects of elevated intraocular pressure on mouse retinal ganglion cells.

Authors:  Jianzhong Ji; Peter Chang; Mark E Pennesi; Zhuo Yang; Jian Zhang; Dequan Li; Samuel M Wu; Ronald L Gross
Journal:  Vision Res       Date:  2005-01       Impact factor: 1.886

Review 9.  The dysfunction of the trabecular meshwork during glaucoma course.

Authors:  Sergio Claudio Saccà; Alessandra Pulliero; Alberto Izzotti
Journal:  J Cell Physiol       Date:  2015-03       Impact factor: 6.384

Review 10.  Selective laser trabeculoplasty: current perspectives.

Authors:  Kate E Leahy; Andrew Jr White
Journal:  Clin Ophthalmol       Date:  2015-05-11
View more
  2 in total

1.  Anti-glaucoma potential of hesperidin in experimental glaucoma induced rats.

Authors:  Baiyang Lu; Xue Wang; Zengjin Ren; Haitao Jiang; Bingqian Liu
Journal:  AMB Express       Date:  2020-05-18       Impact factor: 3.298

2.  Stimulation of α7 nAChR leads to regeneration of damaged neurons in adult mammalian retinal disease models.

Authors:  Sarah E Webster; Nathan C Sklar; Jake B Spitsbergen; Megan L Stanchfield; Mark K Webster; David M Linn; Deborah C Otteson; Cindy L Linn
Journal:  Exp Eye Res       Date:  2021-08-01       Impact factor: 3.770

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.